PROSTATE WARRIORS - The latest news about prostate cancer
  • Home
  • Cancer 1O1
  • News
  • TRIALS TABLE
  • Navigator
  • Newsletters
  • BATcave
  • tE2 Initiative
  • Contact
  • Search
  • Menu Menu
  • X

BA1106 Antibody Shows Promise in Early Trials In Solid Tumors

April 26, 2025/in Clinical Trial, Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-26 19:50:552025-04-26 19:50:55BA1106 Antibody Shows Promise in Early Trials In Solid Tumors

Q702 Drug Shows Promise in Early Trials: Could Be Useful Against Prostate Cancer

April 25, 2025/in Clinical Trial, Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-25 20:54:382025-04-25 20:54:38Q702 Drug Shows Promise in Early Trials: Could Be Useful Against Prostate Cancer

A New Potential Treatment For Early Prostate Cancer: TGW101

April 25, 2025/in Clinical Trial, Non-Metastatic, Not PCa related, Phase 1/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-25 19:45:182025-04-25 19:45:18A New Potential Treatment For Early Prostate Cancer: TGW101

Phase 1 Results: Personalized Cancer Vaccine PGV001 Shows Promise Across Multiple Cancer Types

April 7, 2025/in Clinical Trial, Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-04-07 07:00:172025-04-07 08:08:30Phase 1 Results: Personalized Cancer Vaccine PGV001 Shows Promise Across Multiple Cancer Types

The Microbiome: A Frontline Barrier and Emerging Ally in Cancer Treatment

February 11, 2025/in Clinical Trial, Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-02-11 10:27:462025-02-11 10:31:23The Microbiome: A Frontline Barrier and Emerging Ally in Cancer Treatment

BR111: A New ADC Therapy That Could Work Also For Prostate Cancer

February 11, 2025/in Clinical Trial, Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-02-11 09:37:332025-02-11 10:32:11BR111: A New ADC Therapy That Could Work Also For Prostate Cancer

Phase 1 Trial of a Polynucleotide Kinase/Phosphatase (PNKP) Inhibitor

January 10, 2025/in Clinical Trial, Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2025-01-10 08:56:012025-01-10 08:56:01Phase 1 Trial of a Polynucleotide Kinase/Phosphatase (PNKP) Inhibitor

Phase 1 Trial: Simple Dietary Supplement Could Supercharge Cancer-Fighting Immune Cells

December 30, 2024/in Clinical Trial, Not PCa related/by Max
Read more
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png 0 0 Max https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png Max2024-12-30 09:27:272025-01-05 09:22:33Phase 1 Trial: Simple Dietary Supplement Could Supercharge Cancer-Fighting Immune Cells

Menu

  • Home
  • Cancer 1O1
  • News
  • TRIALS TABLE
  • Navigator
  • Newsletters
  • BATcave
  • tE2 Initiative
  • Contact

Categories

Archives

Project Navigator


Let's try to finance it!

A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.

Tags

177Lu-PSMA-617 abiraterone abiraterone acetate ADC ADT ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy

Latest Posts

  • Newsletter 44/2026 November 1, 2026
  • UPDATE: JNJ-6143 RIPTAC Advances to Randomized Phase 3 Trial With Overall Survival Endpoint October 31, 2026
  • Phase 1/2 Trial Will Investigate STAR0602 Plus Nivolumab in Metastatic Prostate Cancer October 31, 2026
  • TIDE-PC Phase 2 Trial Will Test Testosterone-Guided ADT De-Escalation in Metastatic Prostate Cancer October 31, 2026
© Copyright 2024 - 2026 PROSTATE WARRIORS - The latest news about prostate cancer - Supporters' Hall
  • X
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlySettings

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy
Accept settingsHide notification only